George Yared, MD
Gastroenterology · Tifton, GANPI 1790786226
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,000 of the $12,279 with a category attached, or 73.3%. AbbVie accounts for 83.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $6,015 and has fallen 97.8% since, to $131 in 2025.
Across 170 payments — averaging $72.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$10K
- Takeda Pharmaceuticals U.S.A., Inc.$476
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$250
- Covidien LP$220
- Johnson & Johnson$198
- Endogastric Solutions, Inc$161
- plus $779 from 14 others
What the payments were for
- Speaking & faculty fees$9,00073%
- Travel & lodging$3553%
- Food & beverage$2,92424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 69 | $10,195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $476 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $250 |
| Covidien LP | 1 | $220 |
| Johnson & Johnson | 13 | $198 |
| Endogastric Solutions, Inc | 6 | $161 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Ironwood Pharmaceuticals, Inc | 7 | $109 |
| Boston Scientific | 2 | $86 |
| Medtronic | 1 | $82 |
| Pfizer | 4 | $82 |
| Intercept Pharmaceuticals, Inc. | 4 | $70 |
| Cook Medical LLC | 1 | $54 |
| Evoke Pharma, Inc. | 3 | $48 |
| Dova Pharmaceuticals | 3 | $40 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Merck | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,279 in reported general payments places this provider in the 85th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 12 | $537,605 |
| CreonLipase/Protease/Amylase | 163 | $450,238 |
| StelaraUstekinumab | 15 | $409,981 |
| LinzessLinaclotide | 53 | $46,595 |
| Dexlansoprazole DrDexlansoprazole | 48 | $16,467 |
| MovantikNaloxegol Oxalate | 30 | $16,114 |
| MotegrityPrucalopride Succinate | 12 | $8,448 |
| Esomeprazole Magnesium | 120 | $5,195 |
| Mesalamine ErMesalamine | 13 | $4,874 |
| Pantoprazole Sodium | 395 | $4,781 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 68 | $4,124 |
| AprisoMesalamine | 12 | $3,147 |
| Omeprazole | 164 | $3,147 |
| Lubiprostone | 33 | $2,585 |
| Dicyclomine Hcl | 98 | $2,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex, Motegrity | $476 | $546,05424 claims |
| AbbVieCreon, Linzess | $10,195 | $496,833216 claims |
| Johnson & JohnsonStelara | $198 | $409,98115 claims |
| Redhill Biopharma Inc.Movantik | $13 | $16,11430 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCApriso | $250 | $3,14712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Tifton
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Satish RaoAugusta$335K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
- Aja McCutchenWinder$310K
- Bruce SalzbergSuwanee$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.